Jefferies Financial Group Inc. Has $5.75 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Jefferies Financial Group Inc. grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 98.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 83,100 shares of the company's stock after purchasing an additional 41,300 shares during the quarter. Jefferies Financial Group Inc. owned 0.07% of Henry Schein worth $5,751,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Investment Management Corp VA ADV acquired a new stake in shares of Henry Schein in the 4th quarter valued at $32,000. Venturi Wealth Management LLC lifted its position in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC increased its position in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after buying an additional 323 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares during the last quarter. Finally, Allworth Financial LP grew its stake in Henry Schein by 180.7% in the 4th quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after acquiring an additional 609 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently weighed in on HSIC. UBS Group cut their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Piper Sandler cut their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Barrington Research cut their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Finally, Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Price Performance

Henry Schein stock traded down $1.42 during midday trading on Thursday, hitting $71.98. The company's stock had a trading volume of 1,438,703 shares, compared to its average volume of 1,667,064. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock's 50-day moving average price is $67.62 and its 200-day moving average price is $71.59. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a market capitalization of $8.76 billion, a PE ratio of 29.62, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was down .1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.10 earnings per share. Analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Transactions at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.